/Companies

Spiral Genetics

acquired by OmiciaYC W19

Seattle, US · Founded 2009 · Delaware corporation · 7 employees · 14 known investors

Find your way into Spiral Genetics

Sign up to see every warm intro you have to Spiral Genetics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Spiral Genetics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Spiral Genetics builds genomic data mining software for comparing large populations of whole human genomes using machine learning, aimed at enabling new diagnostics and druggable targets. Its customers include genetics testing companies, national governments, and pharmaceutical companies.

Also known as Inc.

Founders & leadership· Y Combinator alumni (W19)

Spiral Genetics was founded in 2009 by Adina Mangubat, Jeremy Bruestle, and Alindrina Mangubat.

AMAdina Mangubat
Adina MangubatCo-founder · President and CEO2017–2021Adina Mangubat is CEO and co-founder of Spiral Genetics, a software company focused on population-scale genetic comparison for drug and diagnostic development.
JB
Jeremy BruestleCo-founder
AM
Alindrina MangubatCo-founder
NS
Niranjan ShekarVice President Science
RF
Rob FlickengerDirector of Engineering

Board

RJ
Richard JacrouxBoard director

Investors · 14

415 CapitalreportedMunich · $5.4M – $16.2M

How we know: Y Combinator's founder network · Not right? Tell us

CP VenturesreportedNorth Sydney · $100K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

DFJreportedSan Mateo

How we know: funding news · Not right? Tell us

EverHaüsreported

How we know: Y Combinator's founder network · Not right? Tell us

Hanmi Healthcarereported

How we know: Y Combinator's founder network · Not right? Tell us

Iron Shore Investmentsreported

How we know: Y Combinator's founder network · Not right? Tell us

MicroVenturesreportedAustin

How we know: Y Combinator's founder network · Not right? Tell us

MyAsiaVCreportedSeattle

How we know: Y Combinator's founder network · Not right? Tell us

Prasetia DwidharmareportedJakarta Pusat

How we know: Y Combinator's founder network · Not right? Tell us

Two Bear CapitalreportedWhitefish · $3M – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$350K disclosed across 1 round · 2015

▶$350KraisedMay 2016 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard JacrouxDirector
  • Jeremy BruestleDirector
  • Alindrina MangubatExecutive Officer, Director
Offering amount
$350K
Amount sold
$350K
Minimum investment
$50K
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Ochre BioOchre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models. The company aims to address the global shortage of liver transplants by developing new treatment options for liver fibrosis and cirrhosis.
Arpeggio BioArpeggio Bio is a pharmaceutical company that uses AI and high-throughput RNA-sequencing to develop drugs targeting transcription factors, including historically "undruggable" proteins such as NRF2, TEAD, and GPX4. Its lead program targets IO-resistant melanoma, and it has worked on rare disease and inflammation programs through partnerships.
Coral GenomicsCoral Genomics develops clinical laboratory tests that combine molecular, functional, and clinical data to predict the most effective treatments for patients with autoimmune diseases. The company also works on addressing a subpopulation of patients who do not respond to current autoimmune therapies.
Kern SystemsKern Systems develops DNA-based data storage, using enzymatic DNA synthesis and custom digital codecs to encode information. It aims to build scalable information infrastructure stored in DNA as an alternative to current memory technologies.
GenomelinkGenomelink develops a platform that provides individuals with access to and management of their genomic data, leveraging advances in DNA sequencing technology. The company serves consumers seeking personal genetic information and operates in the genomics and digital health sector.

Companies working in the same space as Spiral Genetics.

Legal entities · 1

corporate structure
Spiral Genetics, Inc.

In the news

Frequently asked questions

What does Spiral Genetics do?
Spiral Genetics builds genomic data mining software for comparing large populations of whole human genomes using machine learning, aimed at enabling new diagnostics and druggable targets. Its customers include genetics testing companies, national governments, and pharmaceutical companies.
Who founded Spiral Genetics?
Spiral Genetics was founded by Adina Mangubat, Jeremy Bruestle, Alindrina Mangubat in 2009.
Who are Spiral Genetics's investors?
Spiral Genetics's investors include Y Combinator, SeaChange, 415 Capital, CP Ventures, DFJ, EverHaüs, Hanmi Healthcare, Iron Shore Investments and 6 more.
How much funding has Spiral Genetics raised?
Spiral Genetics has disclosed $350K raised across 1 round.
Where is Spiral Genetics headquartered?
Spiral Genetics is headquartered in Seattle, US.